MDxHealth SA (MDXH)
MDXH trades on Nasdaq in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.6600
+9.29% on the day
Market cap
$63.0M
Micro cap
Revenue · 2025
$107.9M
No prior year to compare
Net income · 2025
-$33.5M
-31.1% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 20-F (ifrs-full:Revenue), period ending 2025-12-31, https://www.sec.gov/Archives/edgar/data/1872529/000121390026039540/0001213900-26-039540-index.htm. Net income: SEC 20-F (ifrs-full:ProfitLossAttributableToOwnersOfParent), period ending 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | MDXH on Nasdaq |
| Sector | Health Care |
| Industry | Medical Specialities |
| Country | Belgium |
| IPO year | 2021 |
| SEC CIK | 0001872529 |
| SEC industry code | Services-Medical Laboratories |
| Incorporated in | C9 |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $107.9M |
| Net income | -$33.5M |
| Operating income | Not in SEC XBRL data |
| Net margin | -31.1% |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | Not in SEC XBRL data |
| Total assets | Not in SEC XBRL data |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.6× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS SUPPLEMENT | 424B5 | 2026-08-13 |
| Latest annual report ANNUAL REPORT | 20-F | 2026-04-03 |
| Latest quarterly / interim REPORT OF FOREIGN PRIVATE ISSUER | 6-K | 2026-09-03 |
Source: SEC EDGAR submissions feed, 180 recent filings. All filings on EDGAR.
Peers in Medical Specialities
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| SERA | Sera Prognostics Inc. | $2.04 | -1.45% | $80.5M |
| KEQU | Kewaunee Scientific Corporation | $32.20 | -0.62% | $93.2M |
| BNR | Burning Rock Biotech Limited | $15.00 | 0.00% | $158.2M |
| ACH | Accendra Health Inc. | $0.3151 | -19.31% | $24.2M |
| XGN | Exagen Inc. | $8.48 | +2.79% | $205.4M |
| TLSI | TriSalus Life Sciences Inc. | $4.00 | -3.38% | $246.3M |
| BDSX | Biodesix Inc. | $25.00 | -2.72% | $263.8M |
| YDES | YD Bio Limited | $6.10 | -3.63% | $432.1M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier